Image

Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE)

Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE)

Recruiting
40-65 years
Female
Phase N/A

Powered by AI

Overview

The objective is to evaluate the effect of a nutritional prevention program associated with the consumption of "Primevère margarine" on the quality of life of women at risk of cardiovascular disease after 10 group coaching sessions in nutrition and physical activity.

Description

The objective is to evaluate the effect of a nutritional prevention program associated with the consumption of "Primevère margarine" on the quality of life of women aged 40 to 65 with cardiovascular risk 3 months after 10 group coaching sessions.

The nutritional prevention program includes tools and 10 collective workshops to change the life behaviours (eating habits and physical activity) by assessing :

  • Food balance and diversity
  • Eating behaviour and representations
  • Level of knowledge in nutrition
  • Level of physical activity and physical inactivity
  • Physical abilities: strength, balance, flexibility, cardio respiratory endurance, recovery capacity
  • Behavioural barriers and educational levers to improve women's cardiovascular health

Eligibility

Inclusion Criteria:

  • BMI > 25kg/m² and/or with a waist circumference > 88 cm
  • Regularly consuming butter and/or "standard" margarine rich in saturated fatty acids

Exclusion Criteria:

  • Regularly consuming "healthy" margarine enriched with omega 3 (Primevere, St Hubert ω3 ...) or with phytosterols (Pro-active)
  • Consuming omega-3 rich food supplements within 3 months of inclusion
  • Treated with lipid-lowering agents (statins), antidiabetic or antihypertensive drugs for less than 3 months
  • Suffering of eating disorders
  • Presenting a medical contraindication to the practice of physical activity
  • Having previously participated in a similar prevention program
  • Suffering from serious chronic diseases (cancer, serious cardiovascular history, etc.)

Study details
    Healthy Volunteers

NCT06380218

Institut Pasteur de Lille

3 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.